Status:

COMPLETED

Assessing the Effects Of Treadmill On LPA, Sitting Time, and Cardiovascular Risk

Lead Sponsor:

University of Minnesota

Conditions:

Sedentary Lifestyle

Risk Factor, Cardiovascular

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to: 1. Evaluate the relative efficacy of a treadmill desk intervention on light physical activity and sitting behaviors at work over four weeks; 2. Evaluate the relative ...

Detailed Description

American workers spend 70-80% of their time at work sitting at a desk, working on a computer, talking on a telephone, and sitting in meetings. Traditional approaches to increase MVPA in the workplace ...

Eligibility Criteria

Inclusion

  • Not currently pregnant or planning to become pregnant during the 11 week study period.
  • Able to read and write in English.
  • No current use of a sit/stand or treadmill desk.
  • Work that is done in a predominately stationary position.
  • Working at UMN West Bank Office Building at least 30 hours per week.
  • Not currently meeting physical activity guidelines.
  • No balance issues (i.e. healthy vestibular system)
  • No contraindications to standing or walking
  • Weight stable for the past 12 months.
  • Taking no more than 3 prescription drugs, with stable dosage, over the past 12 months
  • Answer of no to all Physical Activity Readiness-Questionnaire (PAR-Q) questions

Exclusion

  • Currently pregnant or actively trying to become pregnant during the 14 week study period.
  • Unable to read and write in English.
  • Working less than 30 hours per week.
  • Currently meeting physical activity guidelines.
  • Non-sedentary job.
  • Current use of treadmill desk
  • Any reported balance problems
  • Anyone with contraindications to standing or walking
  • Weight fluctuations of more than +/- 10% of their body weight in the past year
  • Individuals taking more than 4 prescription drugs and/or unstable dosage of medications over the past 12 months if taking 3 or less.
  • Answer of yes to any PAR-Q questions

Key Trial Info

Start Date :

October 5 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 8 2019

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT03236597

Start Date

October 5 2018

End Date

December 8 2019

Last Update

January 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota West Bank Office Building

Minneapolis, Minnesota, United States, 55454